Spire Healthcare Group PLC Completion of disposal
01 Novembre 2019 - 8:00AM
RNS Non-Regulatory
TIDMSPI
Spire Healthcare Group PLC
01 November 2019
Spire Healthcare Group plc
("Spire Healthcare", "the Company" or "the Group")
Completion of disposal
Spire Healthcare (LSE: SPI), a leading independent hospital
group in the UK, today announces the completion of the sale of two
Spire sites, Baddow Specialist Care Centre and Bristol Cancer
Centre, for a total consideration of GBP12.0 million to
GenesisCare.
As announced on 16 September 2019, the sale of the two sites
completes the first step of the new partnership between Spire
Healthcare and GenesisCare to create a national end-to-end private
cancer care pathway. As part of the partnership, Spire Healthcare
will retain 50% share of chemotherapy gross profits generated at
Bristol Cancer Centre and will provide diagnostics and surgery for
this location. GenesisCare will contribute its leading expertise in
radiotherapy, treatment planning, and innovation in areas such as
its electronic multidisciplinary team approach.
-Ends-
For further information please contact:
Spire Healthcare Cora McCallum,
Head of Investor Relations +44 (0)20 7427 9169
Instinctif Partners
Damian Reece
Guy Scarborough +44 (0)20 7457 2020
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare is a leading independent hospital group in the
United Kingdom, with 39 private hospitals and 8 clinics across
England, Wales and Scotland.
Spire Healthcare delivered tailored, personalised care to
approximately 260,000 in-patients and daycase patients in 2018, and
is the leading private provider, by volume, of knee and hip
operations in the United Kingdom. The Group's well located and
scalable hospitals have delivered successful and award-winning
clinical outcomes, positioning the Group well with patients,
consultants, the NHS, GPs and Private Medical Insurance ("PMI")
providers. Spire treats patients through a variety of routes
including PMI, Self-pay and the NHS, providing the Group with
diversified access to the expected growth opportunities in the UK
healthcare market, which faces significant supply challenges as a
result of NHS budget constraints and increasing demand from a
growing population with longer life expectancy.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRACKDDNOBDDQKN
(END) Dow Jones Newswires
November 01, 2019 03:00 ET (07:00 GMT)
Grafico Azioni Spire Healthcare (LSE:SPI)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Spire Healthcare (LSE:SPI)
Storico
Da Apr 2023 a Apr 2024